Join the Ovarian Cancer group to help and get support from people like you.
Ovarian Cancer News (Page 3)
Related terms: Cancer, Ovarian, Cancer, Ovaries
FDA Grants Accelerated Approval to Rubraca (rucaparib) for Advanced Ovarian Cancer
December 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for...
FDA Approves Avastin (bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer
South San Francisco, CA – December 6, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Medwatch Alert: Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use
ISSUE: The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective...
FDA Approves Lynparza (olaparib) to Treat Advanced Ovarian Cancer
December 19, 2014 – The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with...
FDA Approves Avastin (bevacizumab) Plus Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer
South San Francisco, Calif. – November 14, 2014 – Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Avastin in combination with...
FDA Medwatch Alert: Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified
ISSUE: Hospira, Inc. is further informing the general public about a previously communicated voluntary user-level recall of three lots of Carboplatin Injection due to visible particulates identified...
Ask a question
To post your own question to this support group, sign in or create an account.